Teva Pharma receives US FDA clearance to begin phase III chronic heart failure ... pharmabiz.com Mesoblast Limited's development and commercial partner Teva Pharmaceuticals Industries Ltd has received the United States Food and Drug Administration (FDA clearance to begin phase III trial in patients with chronic congestive heart failure using ... |
